METFORMINT
Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99245377
- Mark type
- Stylized text
- Filed
- 20 Jun 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Anthony E Bennett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels; Pharmaceutical preparations for the treatment of diabetes and pre-diabetes, and for managing blood sugar levels administered as an oral spray; Anti-diabetic pharmaceuticals
Owner
- Aspargo Laboratories, Inc., New York, NY, US
- Aspargo Laboratories, Inc., New York, NY, US
Prosecution history
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Nov 2025 — ASSIGNED TO EXAMINER
- 20 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Jun 2025 — NEW APPLICATION ENTERED